Search

everythinglearnresearchcommunity

for

Search:↓

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Botanical treatments like saw palmetto, rosemary oil, and ginseng may help reduce hair loss in menopausal women.

Better supportive care is needed to manage chemotherapy side effects.

Dissolving microneedles offer efficient, minimally invasive drug delivery through the skin.

New drug uses show promise but need more research.

QMSI is a valuable method for studying drug penetration in skin tissues.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Combining scalp cooling with a special lotion helps prevent severe hair loss in breast cancer patients undergoing chemotherapy.

Permanent micropigmentation can help cancer survivors feel better about themselves by restoring eyebrows lost during chemotherapy.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Advanced human skin models improve drug development and could replace animal testing.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.